{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:52:02Z","timestamp":1793843522618,"version":"4.6.1"},"reference-count":65,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R56AI129348"],"award-info":[{"award-number":["1R56AI129348"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R56AI122655"],"award-info":[{"award-number":["1R56AI122655"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4975A1\/2"],"award-info":[{"award-number":["RG 4975A1\/2"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Plaque psoriasis is a common inflammatory condition of the skin characterized by red, flaking lesions. Current therapies for plaque psoriasis target many facets of the autoimmune response, but there is an incomplete understanding of how oxidative damage produced by enzymes such as myeloperoxidase contributes to skin pathology. In this study, we used the Aldara (Imiquimod) cream model of plaque psoriasis in mice to assess myeloperoxidase inhibition for treating psoriatic skin lesions. To assess skin inflammation severity, an innovative mouse psoriasis scoring system was developed. We found that myeloperoxidase inhibition ameliorated psoriasis severity when administered either systemically or topically. The findings of this study support the role of oxidative damage in plaque psoriasis pathology and present potential new therapeutic avenues for further exploration.<\/jats:p>","DOI":"10.3390\/antiox10091338","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T04:24:27Z","timestamp":1629865467000},"page":"1338","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice"],"prefix":"10.3390","volume":"10","author":[{"given":"Savannah D.","family":"Neu","sequence":"first","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI 53201, USA"},{"name":"Department of Microbiology & Immunology, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3841-2575","authenticated-orcid":false,"given":"Anna","family":"Strzepa","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI 53201, USA"},{"name":"Department of Medical Biology, Jagiellonian University Medical College, 31-034 Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Pediatric Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6464-5006","authenticated-orcid":false,"given":"Mary G.","family":"Sorci-Thomas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology & Molecular Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9706-5297","authenticated-orcid":false,"suffix":"Jr.","given":"Kirkwood A.","family":"Pritchard","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Pediatric Surgery, Medical College of Wisconsin, Milwaukee, WI 53226, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4275-2457","authenticated-orcid":false,"given":"Bonnie N.","family":"Dittel","sequence":"additional","affiliation":[{"name":"Versiti Blood Research Institute, Milwaukee, WI 53201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sterry, W. (2014). Psoriasis: Diagnosis and Management, Wiley.","DOI":"10.1002\/9781118661796"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0625.2000.009001001.x","article-title":"Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: A neutrophil-associated inflammation-boosting loop","volume":"9","author":"Terui","year":"2000","journal-title":"Exp. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1111\/bjd.15610","article-title":"The global state of psoriasis disease epidemiology: A workshop report","volume":"177","author":"Griffiths","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2165\/00002018-200225130-00003","article-title":"Comparative tolerability of systemic treatments for plaque-type psoriasis","volume":"25","author":"McClure","year":"2002","journal-title":"Drug Saf."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Horn, E.J., Fox, K.M., Patel, V., Kimball, A.B., Gordon, K.B., and Lebwohl, M.G. (2008). Treatment Satisfaction and Health-Related Quality of Life among Individuals with Psoriasis: National Psoriasis Foundation Survey Findings, Psoriasis Forum; Sage.","DOI":"10.1177\/247553030814a00205"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1084\/jem.178.4.1271","article-title":"Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis","volume":"178","author":"Hammerberg","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"Zaba","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1096\/fasebj.14.3.565","article-title":"Response of keratinocytes from normal and psoriatic epidermis to interferon-\u03b3 differs in the expression of zinc-\u03b12-glycoprotein and cathepsin D","volume":"14","author":"Chen","year":"2000","journal-title":"FASEB J."},{"key":"ref_12","first-page":"218","article-title":"Cyclosporin in psoriasis: Continuous monotherapy versus intermittent long-term therapy","volume":"9","author":"Ozawa","year":"1999","journal-title":"Eur. J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-3083.1985.tb01905.x","article-title":"The Effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis","volume":"22","author":"Baker","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0167-5699(86)90005-8","article-title":"Psoriasis: A disease of abnormal Keratinocyte proliferation induced by T lymphocytes","volume":"7","author":"Valdimarsson","year":"1986","journal-title":"Immunol. Today"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1016\/S0091-6749(02)81916-9","article-title":"Alefacept selectively reduces memory-effector (CD45RO+) T cells and improves clinical outcomes in psoriasis and psoriatic arthritis","volume":"109","author":"Dinant","year":"2002","journal-title":"J. Allergy Clin. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jid.2008.294","article-title":"Functional characterization of IL-17F as a selective neutrophil attractant in psoriasis","volume":"129","author":"Watanabe","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-0716-0154-9_26","article-title":"Neutrophil, methods and protocols","volume":"2087","author":"Cichon","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00441-017-2780-z","article-title":"The neutrophil: One cell on many missions or many cells with different agendas?","volume":"371","author":"Christoffersson","year":"2018","journal-title":"Cell Tissue Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/0076-6879(88)62102-1","article-title":"Human neutrophil degranulation","volume":"162","author":"Wright","year":"1988","journal-title":"Methods Enzymol."},{"key":"ref_20","first-page":"S15","article-title":"In vivo role of myeloperoxidase for the host defense","volume":"57","author":"Aratani","year":"2004","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fimmu.2019.00746","article-title":"Neutrophil extracellular traps promote inflammatory responses in psoriasis via activating epidermal TLR4\/IL-36R crosstalk","volume":"10","author":"Shao","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0003-9861(62)90321-1","article-title":"Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization","volume":"96","author":"Schultz","year":"1962","journal-title":"Arch Biochem. Biophys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00000542-200210000-00021","article-title":"Myeloperoxidase-associated tyrosine nitration after intratracheal administration of lipopolysaccharide in rats","volume":"97","author":"Hataishi","year":"2002","journal-title":"Anesthesiology"},{"key":"ref_26","first-page":"1","article-title":"Myeloperoxidase targets oxidative host attacks to Salmonella and prevents collateral tissue damage","volume":"2","author":"Forrer","year":"2017","journal-title":"Nat. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9439","DOI":"10.1073\/pnas.1707032114","article-title":"Immune evasion by a staphylococcal inhibitor of myeloperoxidase","volume":"114","author":"Ramyar","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.38299","article-title":"Endogenous myeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis","volume":"66","author":"Odobasic","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9440(10)64036-9","article-title":"Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes","volume":"158","author":"Sugiyama","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1006\/bbrc.2002.6724","article-title":"Macrophage activation includes high intracellular myeloperoxidase activity","volume":"292","author":"Rodrigues","year":"2002","journal-title":"Biochem. Bioph. Res. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12291-010-0043-9","article-title":"Role of oxidative stress in various stages of psoriasis","volume":"25","author":"Kadam","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ple\u0144kowska, J., Gabig-Cimi\u0144ska, M., and Mozolewski, P. (2020). Oxidative Stress as an Important Contributor to the Pathogenesis of Psoriasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176206"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1194\/jlr.M038273","article-title":"N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor 1 [S]","volume":"54","author":"Zhang","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2017.05.002","article-title":"Myeloperoxidase: A new player in autoimmunity","volume":"317","author":"Strzepa","year":"2017","journal-title":"Cell Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jnc.13426","article-title":"Inhibition of myeloperoxidase at the peak of experimental autoimmune encephalomyelitis restores blood-brain barrier integrity and ameliorates disease severity","volume":"136","author":"Zhang","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"608871","DOI":"10.3389\/fimmu.2020.608871","article-title":"Neutrophil-derived myeloperoxidase facilitates both the induction and elicitation phases of contact hypersensitivity","volume":"11","author":"Strzepa","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-016-0583-x","article-title":"Inhibition of myeloperoxidase oxidant production by N-acetyl lysyltyrosylcysteine amide reduces brain damage in a murine model of stroke","volume":"13","author":"Yu","year":"2016","journal-title":"J. Neuroinflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1194\/jlr.M038281","article-title":"Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice 1 [S]","volume":"54","author":"Zhang","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23\/IL-17 Axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/dev.420120406","article-title":"Three parameters affecting interlitter variations","volume":"12","author":"Woods","year":"1979","journal-title":"Dev. Psychobiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijrobp.2012.12.009","article-title":"A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: Trans Tasman Radiation Oncology Group (TROG) 04.01","volume":"86","author":"Graham","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1194\/jlr.M600370-JLR200","article-title":"Inflammation and skin cholesterol in LDLr\u2212\/\u2212, apoA-I\u2212\/\u2212 mice: Link between cholesterol homeostasis and self-tolerance?","volume":"48","author":"Zabalawi","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9440(10)63480-3","article-title":"Induction of fatal inflammation in LDL receptor and ApoA-I double-knockout mice fed dietary fat and cholesterol","volume":"163","author":"Zabalawi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-4939-1212-4_16","article-title":"Aldara-induced psoriasis-like skin inflammation: Isolation and characterization of cutaneous dendritic cells and innate lymphocytes","volume":"1193","author":"Wohn","year":"2014","journal-title":"Methods Mol Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2009.07.004","article-title":"Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles","volume":"62","author":"Swanson","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Lauffer","year":"2018","journal-title":"J. Allergy Clin. Immun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/247553031700200307","article-title":"National psoriasis foundation priorities for patient-centered research: Proceedings from the 2016 conference","volume":"2","author":"Afifi","year":"2017","journal-title":"J. Psoriasis Psoriatic Arthritis"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1523-1747.ep12384205","article-title":"Patient measurement of psoriasis disease severity with a structured instrument","volume":"102","author":"Fleischer","year":"1994","journal-title":"J. Investig. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5021\/ad.2015.27.5.557","article-title":"Reduction of inter-rater and intra-rater variability in psoriasis area and severity index assessment by photographic training","volume":"27","author":"Youn","year":"2015","journal-title":"Ann. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0008-8749(89)90189-5","article-title":"The C57BL\/6 nude, beige mouse: A model of combined T cell and NK effector cell immunodeficiency","volume":"120","author":"Pflumio","year":"1989","journal-title":"Cell Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/372103a0","article-title":"New member of the winged-helix protein family disrupted in mouse and rat nude mutations","volume":"372","author":"Nehls","year":"1994","journal-title":"Nature"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17460441.2018.1463214","article-title":"Murine models of psoriasis and their usefulness for drug discovery","volume":"13","author":"Chuang","year":"2018","journal-title":"Expert Opin. Drug Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0846.1995.tb00013.x","article-title":"Clinical testing of new drugs for lesional skin diseases such as psoriasis A new delivery system","volume":"1","author":"Farber","year":"1995","journal-title":"Skin Res. Technol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/B978-0-12-185291-7.50018-7","article-title":"Continuous central nervous system infusion with Alzet osmotic pumps","volume":"21","author":"Hagg","year":"1994","journal-title":"Methods Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0076-6879(85)12037-9","article-title":"Osmotic delivery systems for research","volume":"112","author":"Fara","year":"1985","journal-title":"Methods Enzymol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fnins.2019.00990","article-title":"Myeloperoxidase deficiency inhibits cognitive decline in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"13","author":"Volkman","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1128\/IAI.00910-09","article-title":"Myeloperoxidase selectively binds and selectively kills microbes","volume":"79","author":"Allen","year":"2011","journal-title":"Infect Immun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0304-4165(96)00014-1","article-title":"Binding of myeloperoxidase to bacteria: Effect on hydroxyl radical formation and susceptibility to oxidant-mediated killing","volume":"1290","author":"Britigan","year":"1996","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000232303","article-title":"Topical treatment of psoriasis","volume":"38","author":"Kamili","year":"2009","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000069029","article-title":"The topical treatment of psoriasis","volume":"16","author":"Kerkhof","year":"2003","journal-title":"Skin Pharmacol. Physiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(08)60725-4","article-title":"Efficacy and safety of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","volume":"371","author":"Leonardi","year":"2008","journal-title":"Lancet"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","article-title":"Anti\u2013interleukin-17 monoclonal antibody Ixekizumab in chronic plaque psoriasis","volume":"366","author":"Leonardi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-012-8301-7","article-title":"Biologic therapies in the treatment of psoriasis: A comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring","volume":"44","author":"Sivamani","year":"2013","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_65","first-page":"1","article-title":"The economic burden of psoriasis with high comorbidity among privately insured patients in the United States","volume":"22","author":"Pilon","year":"2018","journal-title":"J. Med. Econ."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/9\/1338\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:51:02Z","timestamp":1760165462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/10\/9\/1338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":65,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["antiox10091338"],"URL":"https:\/\/doi.org\/10.3390\/antiox10091338","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}